VotedBy VotedBy ⌕
Election Day · Tue, Nov 3See how your members of Congress voted →

S. 3116 · 116th Congress

Ending the Diagnostic Odyssey Act of 2019

Key: what the circles and colors mean

Each circle is a bill. The ring fills as it moves through Congress:

IntroducedPassed one chamberPassed both chambersBecame law (gold)Resolution agreed to (full, dark)Failed or vetoed (gray)

Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.

Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.

Never voted on. It didn't reach a floor vote before the 116th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.

4 cosponsors · 3 D, 1 R

3 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.

This bill allows state Medicaid programs to cover whole genome sequencing services for certain individuals.

What it does: CRS summary · Introduced in Senate · Dec 19, 2019

Ending the Diagnostic Odyssey Act of 2019

This bill allows state Medicaid programs to cover whole genome sequencing services for certain individuals.

Specifically, states may cover such services for individuals under the age of 21 (or a lower age, if the state chooses) and for former foster youth under the age of 26 who (1) have been referred or admitted to an intensive care unit or seen by a medical specialist for a suspected genetic or undiagnosed disease, or (2) are suspected by a medical specialist to have a neonatal- or pediatric-onset genetic disease.

The Centers for Medicare & Medicaid Services may award grants to assist states in developing plans to cover such services.

Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov

About this bill and sources

Official title: Ending the Diagnostic Odyssey Act of 2019

Latest action (Dec 19, 2019): Read twice and referred to the Committee on Finance. (Sponsor introductory remarks on measure: CR S7211)

Policy area: Health · Origin: Senate · Introduced: Dec 19, 2019

Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)

No recorded floor vote found.